Navigation Links
Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium

HYDERABAD, India, June 22, 2011 /PRNewswire/ -- Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract research and manufacturing services to customers located in 85 countries, today announced it will unveil its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego June 25-30, 2011.

"It is fitting that we formally launch our new commercial-scale peptide production service at this important gathering of leading peptide experts from around the world," said M.K. "Mike" Anwer, Ph.D., vice president of research & development at Neuland Labs.  "Neuland's extensive experience in producing a variety of synthetic peptides parallels their increasing use as therapeutics and diagnostics, in antibody production and as research tools.  Our expanded service provides rapid access to commercial quantities of affordable, high quality peptides from a company with a 27-year track record of consistently achieving the highest regulatory standards in global pharmaceutical production."

Neuland Labs offers customers peptide production using standard sequential chemical peptide syntheses and segment condensation strategies.  The company employs solid phase peptide synthesis procedures, as well as solution phase methods for shorter length peptides, and segment condensation and ligation techniques for very long peptides.  Neuland researchers have also developed special methods to economically produce large quantities of high value peptide building blocks such as pseudoproline dipeptides.

Dr. Anwer added, "Our researchers have developed expertise in producing peptides of varying lengths and complexity.  We are especially proud of our success in applying advanced methods for handling the aggregation and purification issues inherent in manufacturing long and complex peptides.  Our diverse peptide customers also benefit from our value-added consultative services in analytical R&D and drug design, process development, optimization, validation, scale-up and the entire regulatory review and approval process.  We work with companies of all sizes and are interested in exploring opportunities for collaborative efforts with a variety of potential partners."

For over 25 years Neuland Labs has been at the forefront of supporting drug development through its consulting services and its cGMP contract and API manufacturing.  Neuland scientists have developed more than 300 processes from bench scale to commercial production and have filed more than 400 drug master files worldwide.  The company has a longstanding record of regulatory excellence, as demonstrated by seven successful FDA inspections since 1997, with the most recent completely free of any Form 483 investigational observations.  Neuland's cGMP certifications also include the TGA, EDQM, German Health Authority, ISO 14001, ISO 27001 and OHSAS 18001.  

"Our new commercial-scale peptide manufacturing service reflects our ongoing strategy to leverage Neuland Labs' innovative scientists, world-class manufacturing expertise, established infrastructure and reputation for quality to expand into new market segments.  At a time when efficiency is critical to business success, we expect that our commitment to cost effectiveness, regulatory rigor and customer service will be a welcome option for peptide researchers and manufacturers," noted Sucheth R. Davuluri, chief executive officer at Neuland Labs.

More information on Neuland's peptide synthesis capabilities is available at Booth #37 at the 22nd American Peptide Symposium, which will be held June 25-30, 2011 at the Sheraton Hotel and Marina in San Diego, California. 

About the American Peptide Society SymposiumEstablished in 1968 by the American Peptide Society, this biannual Symposium assembles national and international peptide scholars, researchers, educators and students together with corporate exhibitors and sponsors. The Symposium brings together investigators of varying backgrounds, with the goal of stimulating discussion, and catalyzing multidisciplinary collaborations in order to push the frontiers of peptide science.  For more information, visit

About Neuland Laboratories, Ltd.

For over 25 years Neuland Labs has been at the forefront of supporting drug development through its consulting services and its cGMP contract and API manufacturing.  The company is committed to research, supporting a state-of-the-art R&D operation.  Neuland Labs is listed on India's National Stock Exchange under the symbol NEULANDLAB and on the Bombay Stock Exchange under code 524558.  For more information, visit Contacts:Neuland Laboratories Limited

US-Neuland Laboratories Inc.

US MediaRavikant Tadinada  

Thomas Speace

BioCom Partners/Brandwidth Solutions+91 9885681385

President & CEO


(949) 218-1768


SOURCE Neuland Laboratories Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neuland Labs Reports Financial Results for Fiscal Year 2011
2. Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting
3. Multiple Sclerosis Association of America Launches Mobile Phone App for the Multiple Sclerosis Community
4. Ethicon Endo-Surgery Launches ENSEAL® G2 Super Jaw
5. Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform
6. Vinomis Laboratories Launches Vindurance Challenge to Substantiate Claims of Enhanced Physical Endurance with Use of Resveratrol and Quercetin
7. MedeAnalytics Launches Value-Based Purchasing Resource Center
8. The Institute for Specialized Medicine Launches GLUTEN-FREE REMEDIES, a New Line of Gluten-free Food Supplements and Herbs.
9. ViroPharma Launches Swell, an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
10. Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
11. Mylan Launches Generic Version of Roxicodone® Tablets
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015  SRI International ... to $100 million over five years by the ... part of the National Institutes of Health, for ... acute or delayed effects of radiation exposure. Under ... division of SRI International will provide services, facilities, ...
(Date:10/13/2015)... , Oct. 13, 2015  Nanomedical Diagnostics, a ... in research and diagnostics, announces the completion of ... led by Serra Ventures. ... providing low-cost, easy-to-use monitoring and diagnostic platforms that ... The funding round will enable the company to ...
(Date:10/13/2015)... , Oct. 13 2015 ... of the "US & European markets for ... to their offering. --> ) ... & European markets for Meniscal Repair - 16 ... --> Research and Markets ( ) ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... ... ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a technology company ... health programs and interventions via mobile devices that provide a framework for the ...
(Date:10/13/2015)... Houston, TEXAS (PRWEB) , ... October 13, 2015 ... ... firm and solution provider of IBM software products, introduced a new company, RightSensor™ ... sensor systems and data communications capability. RightSensor™ provides a fully-managed approach for ...
(Date:10/13/2015)... ... October 13, 2015 , ... NavaFit Inc. today announced the launch of its ... with, participate in local fitness & sporting events, and stay motivated. Users ... medical costs drive us to get more serious about fitness and wellness, individuals are ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... kind product that targets the unique health needs of new moms. Postnatal ... Pregnancy Association ( ), utilizes Nordic Naturals’ exclusive, new, ultra-concentrated omega-3 ...
(Date:10/13/2015)... ... 13, 2015 , ... California Southern University has named Dr. ... her Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern ... Dr. McLeod’s long and successful nursing practice included a variety of patient care, ...
Breaking Medicine News(10 mins):